Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
Authors
Keywords
-
Journal
Journal of Orthopaedic Surgery and Research
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-02-23
DOI
10.1186/s13018-023-03623-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack
- (2022) Yuan Fang et al. HEPATOLOGY
- The role of lipids in cancer progression and metastasis
- (2022) Miguel Martin-Perez et al. Cell Metabolism
- Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 Biology
- (2021) Timo Heinrich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition
- (2021) Catherine Vander Linden et al. Cell Reports
- Amino acids in cancer
- (2020) Elizabeth L. Lieu et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- An engineered enzyme that targets circulating lactate to alleviate intracellular NADH:NAD+ imbalance
- (2020) Anupam Patgiri et al. NATURE BIOTECHNOLOGY
- Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease
- (2020) Melanie A. Felmlee et al. PHARMACOLOGICAL REVIEWS
- Lactate as a fulcrum of metabolism
- (2020) George A. Brooks Redox Biology
- Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells
- (2020) Iñigo San-Millán et al. Frontiers in Oncology
- Structural basis of human monocarboxylate transporter 1 inhibition by anti-cancer drug candidates
- (2020) Nan Wang et al. CELL
- The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure
- (2020) Ahmad A. Cluntun et al. Cell Metabolism
- MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer
- (2019) Yueh-Shan Weng et al. Molecular Cancer
- Monocarboxylate transporters in cancer
- (2019) Valéry L. Payen et al. Molecular Metabolism
- Metabolic heterogeneity confers differences in melanoma metastatic potential
- (2019) Alpaslan Tasdogan et al. NATURE
- The Science and Translation of Lactate Shuttle Theory
- (2018) George A. Brooks Cell Metabolism
- Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
- (2018) Don Benjamin et al. Cell Reports
- Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis
- (2018) Cathal Harmon et al. Cancer Immunology Research
- Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
- (2017) Richard A. Noble et al. HAEMATOLOGICA
- Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
- (2017) Richard A. Noble et al. HAEMATOLOGICA
- Metabolic Heterogeneity in Human Lung Tumors
- (2016) Christopher T. Hensley et al. CELL
- Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
- (2016) Gabriela Jiménez-Valerio et al. Cell Reports
- Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling
- (2016) Elizabeth Allen et al. Cell Reports
- Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
- (2016) Laura Pisarsky et al. Cell Reports
- MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
- (2016) Candice Sun Hong et al. Cell Reports
- Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters
- (2015) Ibtissam Marchiq et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway
- (2013) Zhiqiang Zhao et al. CANCER LETTERS
- Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis
- (2013) J. R. Doherty et al. CANCER RESEARCH
- Targeting lactate metabolism for cancer therapeutics
- (2013) Joanne R. Doherty et al. JOURNAL OF CLINICAL INVESTIGATION
- Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis
- (2013) Marnie Collins et al. JOURNAL OF CLINICAL ONCOLOGY
- The SLC16 gene family – Structure, role and regulation in health and disease
- (2013) Andrew P. Halestrap MOLECULAR ASPECTS OF MEDICINE
- Multiple Biological Activities of Lactic Acid in Cancer: Influences on Tumor Growth,Angiogenesis and Metastasis
- (2012) Suveera Dhup et al. CURRENT PHARMACEUTICAL DESIGN
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- The monocarboxylate transporter family-Structure and functional characterization
- (2011) Andrew P. Halestrap IUBMB LIFE
- The monocarboxylate transporter family-Role and regulation
- (2011) Andrew P. Halestrap et al. IUBMB LIFE
- MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
- (2009) C. V. Dang et al. CLINICAL CANCER RESEARCH
- Mitochondria andl-lactate metabolism
- (2008) Salvatore Passarella et al. FEBS LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More